BSEInsider Trading / SAST2d ago · 18 Aug 2026, 10:41 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Surbhit Mukesh Shah & Others
Rekvina Laboratories Ltd · 526075
✦ AI SummaryPromoter Reclassif.
Rekvina Laboratories Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a potential change in control or significant stake acquisition by Surbhit Mukesh Shah and others.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern5/10
Regulatory Risk6/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Rekvina Laboratories Ltd - 526075 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011